249 related articles for article (PubMed ID: 25832864)
1. Hydroxyethyl starch 200/0.5 decreases circulating tumor cells of colorectal cancer patients and reduces metastatic potential of colon cancer cell line through inhibiting platelets activation.
Liang H; Yang C; Zhang B; Wang H; Liu H; Zhao Z; Zhang Z; Wen X; Lai X
Med Oncol; 2015 May; 32(5):151. PubMed ID: 25832864
[TBL] [Abstract][Full Text] [Related]
2. Sevoflurane attenuates platelets activation of patients undergoing lung cancer surgery and suppresses platelets-induced invasion of lung cancer cells.
Liang H; Yang CX; Zhang B; Zhao ZL; Zhong JY; Wen XJ
J Clin Anesth; 2016 Dec; 35():304-312. PubMed ID: 27871548
[TBL] [Abstract][Full Text] [Related]
3. The effect of hydroxyethyl starch 200 kD on platelet function.
Stögermüller B; Stark J; Willschke H; Felfernig M; Hoerauf K; Kozek-Langenecker SA
Anesth Analg; 2000 Oct; 91(4):823-7. PubMed ID: 11004032
[TBL] [Abstract][Full Text] [Related]
4. S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells.
Lu Y; Lian S; Ye Y; Yu T; Liang H; Cheng Y; Xie J; Zhu Y; Xie X; Yu S; Gao Y; Jia L
Pharmacol Res; 2019 Jan; 139():535-549. PubMed ID: 30366102
[TBL] [Abstract][Full Text] [Related]
5. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
Wang JY; Wu CH; Lu CY; Hsieh JS; Wu DC; Huang SY; Lin SR
World J Surg; 2006 Jun; 30(6):1007-13. PubMed ID: 16736329
[TBL] [Abstract][Full Text] [Related]
6. Cytokeratin 20 improves the detection of circulating tumor cells in patients with colorectal cancer.
Welinder C; Jansson B; Lindell G; Wenner J
Cancer Lett; 2015 Mar; 358(1):43-6. PubMed ID: 25528628
[TBL] [Abstract][Full Text] [Related]
7. The effects of high molecular weight hydroxyethyl starch solutions on platelets.
Deusch E; Thaler U; Kozek-Langenecker SA
Anesth Analg; 2004 Sep; 99(3):665-668. PubMed ID: 15333389
[TBL] [Abstract][Full Text] [Related]
8. Effects of two different hydroxyethyl starch solutions (HES200/0.5 vs. HES130/0.4) on the expression of platelet membrane glycoprotein.
Chen G; Yan M; Lu QH; Gong M
Acta Anaesthesiol Scand; 2006 Oct; 50(9):1089-94. PubMed ID: 16987338
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
10. The effects of preloading infusion with hydroxyethyl starch 200/0.5 or 130/0.4 solution on hypercoagulability and excessive platelet activation of patients with colon cancer.
Liang H; Yang CX; Li H; Wen XJ; Zhou QL; Gu MN
Blood Coagul Fibrinolysis; 2010 Jul; 21(5):406-13. PubMed ID: 20614571
[TBL] [Abstract][Full Text] [Related]
11. The effects of hydroxyethyl starches of varying molecular weights on platelet function.
Franz A; Bräunlich P; Gamsjäger T; Felfernig M; Gustorff B; Kozek-Langenecker SA
Anesth Analg; 2001 Jun; 92(6):1402-7. PubMed ID: 11375812
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.
Pesta M; Fichtl J; Kulda V; Topolcan O; Treska V
Anticancer Res; 2013 May; 33(5):2239-43. PubMed ID: 23645782
[TBL] [Abstract][Full Text] [Related]
13. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion.
Rossi F; Rossi E; Pareti FI; Colli S; Tremoli E; Gallo L
Haematologica; 2001 Feb; 86(2):192-8. PubMed ID: 11224490
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of gelatin solutions on platelet function: a comparison with hydroxyethyl starch solutions.
Thaler U; Deusch E; Kozek-Langenecker SA
Anaesthesia; 2005 Jun; 60(6):554-9. PubMed ID: 15918826
[TBL] [Abstract][Full Text] [Related]
16. Differential platelet receptor expression following hydroxyethyl starch infusion in thrombocytopaenic orthotopic liver transplantation recipients.
Jüttner B; Kuse ER; Elsner HA; Heine J; Jaeger K; Piepenbrock S; Scheinichen D
Eur J Anaesthesiol; 2004 Apr; 21(4):309-13. PubMed ID: 15109195
[TBL] [Abstract][Full Text] [Related]
17. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
[TBL] [Abstract][Full Text] [Related]
18. Platelets, circulating tumor cells, and the circulome.
Kanikarla-Marie P; Lam M; Menter DG; Kopetz S
Cancer Metastasis Rev; 2017 Jun; 36(2):235-248. PubMed ID: 28667367
[TBL] [Abstract][Full Text] [Related]
19. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
20. Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation.
Ito H; Miyakoda G; Mori T
Platelets; 2004 Aug; 15(5):293-301. PubMed ID: 15370100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
